RSS
JAZZ icon

Rosenblum Silverman Sutton’s Jazz Pharmaceuticals JAZZ Stock Holding History

Rosenblum Silverman Sutton’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$503K Sell
3,075
-50
-2% -$8.3K 0.22% 59
2014
Q3 		$502K Buy
3,125
+175
+6% +$26.9K 0.23% 59
2014
Q2 		$434K Sell
2,950
-300
-9% -$41.6K 0.2% 57
2014
Q1 		$451K Buy
3,250
+150
+5% +$22.6K 0.21% 62
2013
Q4 		$392K Buy
3,100
+50
+2% +$5.17K 0.19% 64
2013
Q3 		$281K Buy
+3,050
New +$246K 0.15% 64

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Rosenblum Silverman Sutton's JAZZ Position: Q4 2014 in Review

Rosenblum Silverman Sutton reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.6% in Q4 2014, selling an estimated $8.3K and leaving 3,075 shares worth $503K. The position accounts for 0.22% of the portfolio, ranked #59.

Rosenblum Silverman Sutton first reported a position in JAZZ in Q3 2013 and has held it in 6 quarters since. 357 funds tracked by Wall St. Rank hold JAZZ as of Q4 2014.

  • Rosenblum Silverman Sutton held 3,075 shares of Jazz Pharmaceuticals worth $503K as of Q4 2014.
  • Rosenblum Silverman Sutton sold 50 Jazz Pharmaceuticals shares in Q4 2014, an estimated $8.3K.
  • Jazz Pharmaceuticals made up 0.22% of Rosenblum Silverman Sutton's portfolio in Q4 2014, its #59 holding.
  • Rosenblum Silverman Sutton first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 6 quarters since.
  • 357 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2014.

Based on Rosenblum Silverman Sutton's 13F filing for Q4 2014, filed 17 Feb 2015.